Navigation Links
Crystal Diagnostics Successfully Detects Deadly Ebola Virus in less than 20 Minutes
Date:7/9/2015

Crystal Diagnostics (CDx) has successfully detected live Ebola virus with its unique liquid crystal-based rapid pathogen detection system. Those tests were conducted at the University of Texas Galveston Medical Branch Biosafety Level 4 (BSL-4) facilities. Tests demonstrated detection at variable concentrations of live Ebola Zaire in serum samples in less than 20 minutes.

The CDx Xpress System combines proprietary liquid crystal technology with highly specific antibody-coated paramagnetic microspheres to selectively capture and detect Ebola virus faster than other commercial systems.

CDx sells rapid pathogen systems in the Food Safety market to quickly and accurately detect food borne pathogens in a variety of products including meat and produce. The company’s systems are in use in commercial test labs, government agencies, universities, and research facilities, as well as food processors. The Ebola detection project is the first application outside of the food safety arena for CDx.

According to Robert F Garry, PhD, Professor of Microbiology and Immunology at the Tulane University School of Medicine, and Principal Investigator of the Viral Hemorrhagic Fever Consortium (VHFC), “The CDx system promises advantages over other rapid Ebola detection systems, in terms of automated reader results, speed, and consistency.”

President and CEO of Crystal Diagnostics, Jim Bruce, stated that, “We are delighted with the initial results, and following field trials and US Food and Drug Administration device approval, we look forward to contributing to the fight against this deadly disease.”

CDx has applied for grants from the Paul Allen Foundation and the Biomedical Advanced Research and Development Authority (BARDA) division in the U.S. Department of Health and Human Services to complete equipment automation and development of the Ebola test.

About CDx: Crystal Diagnostics was founded in 2006 and is the exclusive licensee of fundamental liquid crystal technologies developed through a research partnership between Kent State University and Northeast Ohio Medical University. For more information about the company or its Xpress Pathogen Detection System, contact CEO Jim Bruce at 720-351-4885 or visit the CDx web site http://www.crystaldiagnostics.com.

Critical reagents used in the CDx test were supplied by the Viral Hemorrhagic Fever Consortium, or "VHFC" (http://www.vhfc.org). The VHFC reagents were developed with the support of the National Institute of Allergy and Infectious Diseases of the National Institutes of Health ("NIH/NIAID"). VHFC members Autoimmune Technologies LLC and Zalgen Labs LLC manufacture the critical reagents.

Read the full story at http://www.prweb.com/releases/2015/07/prweb12838280.htm.


'/>"/>
Source: PRWeb
Copyright©2015 Vocus, Inc.
All rights reserved

Related biology technology :

1. Phytomer Launches MORPHO DESIGNER Contouring Crystal Emulsion
2. Crystal Research Associates, LLC Issues Executive Informational Overview (EIO) on Aeterna Zentaris Inc.
3. Crystal Diagnostics Awarded AOAC-PTM Accreditation for the Rapid Detection of “Big 6” E.coli Food Pathogens
4. The North American crystal oscillator market is expected to reach $623.6 million by 2018 - New Report by MicroMarket Monitor
5. The Asia-Pacific Liquid Crystal on Silicon (LCoS) display market is expected to reach $380.0 million by 2018 - New Report by MicroMarket Monitor
6. Penn team studies nanocrystals by passing them through tiny pores
7. 2-D materials crystalline defects key to new properties
8. Global and Chinese Microcrystalline Cellulose Industry Report 2014
9. Shaping the future of nanocrystals
10. A crystal wedding in the nanocosmos
11. Hepatitis B Foundation to Host Annual Crystal Ball Gala
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2018)... BUFFALO, N.Y. (PRWEB) , ... July 31, 2018 ... ... release of 2 additional CE/IVD marked molecular quality controls to its expanding CE/IVD ... molecular quality controls to our expanding CE/IVD QC offerings. ZeptoMetrix remains entirely committed ...
(Date:7/25/2018)... , ... July 25, 2018 , ... ... biofield energy treated proprietary nutraceutical to combat inflammation and autoimmune disorders. , ... immune function response. The following data was reported:, ...
(Date:7/24/2018)... (PRWEB) , ... July 23, 2018 , ... ... of a biofield energy treated nutraceutical to increase immunity and improve anti-inflammatory, and ... immune function response assessed in the preclinical research were significantly reduced. Results are ...
(Date:7/22/2018)... ... 2018 , ... Mitotech S.A, a Luxembourg based clinical stage ... clinical program in Dry Eye Disease. Under the agreement Essex Bio-Investment will fund ... the first Phase 3 study starting as early as Fall 2018. , ...
Breaking Biology Technology:
(Date:8/7/2018)... ... August 06, 2018 , ... Passersby can’t help ... Southern Illinois University Edwardsville’s University Park. SIUE students are working the “Feedstock Diversity ... These three feedstocks represent conventional biofuels production, advanced biofuels production and cellulosic biofuels ...
(Date:8/7/2018)... BOSTON and SOUTH JORDAN, Utah (PRWEB) , ... August 07, 2018 ... ... communications and collaboration solutions, announced today their new CT Cloud Voice and SIP solutions. ... cloud delivering a scalable and secure, quality voice solution that is far superior to ...
(Date:8/2/2018)... ... August 02, 2018 , ... ... to pharmaceutical and biotech companies, today announced that Mark Jara, principal of the ... people in the life sciences industry. Individuals named to PharmaVOICE 100 are leaders ...
Breaking Biology News(10 mins):